Basic Information
RNALocate ID: | RLID:11003181 |
RNA Symbol: | hsa-miR-455-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-455-5p |
RNA ID: | miRBase:MIMAT0003150 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23663360 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002392 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01002393 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11003178 | Exosome | Pulmonary epithelial cell line (BEAS-2B) | 31520698 |
RLID:11003179 | Exosome | Serum | 18589210 |
RLID:11003180 | Exosome | Brain tissue | 23382797 |
RLID:11003182 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
RLID-D:11000158 | Exosome | Tongue tissue | |
RLID-D:11000506 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-455-5p | Oral squamous cell carcinoma | MNDR-E-MI-51781 |
MNDR | hsa-miR-455-5p | Large cell neuroendocrine cancer | MNDR-E-MI-51782 |
MNDR | hsa-miR-455-5p | Medulloblastoma | MNDR-E-MI-51783 |
MNDR | hsa-miR-455-5p | Small intestinal neuroendocrine tumor | MNDR-E-MI-51784 |
MNDR | hsa-miR-455-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-51785 |
MNDR | hsa-miR-455-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-51786 |
MNDR | hsa-miR-455-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-51787 |
MNDR | hsa-miR-455-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-51788 |
MNDR | hsa-miR-455-5p | Her2-receptor positive breast cancer | MNDR-E-MI-51789 |
MNDR | hsa-miR-455-5p | Small intestine cancer | MNDR-E-MI-51790 |
MNDR | hsa-miR-455-5p | Prostate cancer | MNDR-E-MI-51791 |
MNDR | hsa-miR-455-5p | Gastric cancer | MNDR-E-MI-51792 |
MNDR | hsa-miR-455-5p | Alzheimer disease | MNDR-E-MI-51793 |
MNDR | hsa-miR-455-5p | Intracranial aneurysm | MNDR-E-MI-51794 |
MNDR | hsa-miR-455-5p | Esophageal carcinoma | MNDR-E-MI-51795 |
MNDR | hsa-miR-455-5p | Dysautonomia familial | MNDR-E-MI-51796 |
MNDR | hsa-miR-455-5p | Head and neck cancer | MNDR-E-MI-51797 |
MNDR | hsa-miR-455-5p | Lewy body dementia | MNDR-E-MI-51798 |
MNDR | hsa-miR-455-5p | Graves disease | MNDR-E-MI-51799 |
MNDR | hsa-miR-455-5p | Leukemia | MNDR-E-MI-51800 |
MNDR | hsa-miR-455-5p | Huntington disease | MNDR-E-MI-51801 |
MNDR | hsa-miR-455-5p | Lung cancer | MNDR-E-MI-51802 |
MNDR | hsa-miR-455-5p | Parkinson disease | MNDR-E-MI-51803 |
MNDR | hsa-miR-455-5p | Basal-like breast cancer | MNDR-E-MI-51804 |
MNDR | hsa-miR-455-5p | Neuroendocrine neoplasia | MNDR-E-MI-51805 |
MNDR | hsa-miR-455-5p | Thyroid cancer | MNDR-E-MI-51806 |
MNDR | hsa-miR-455-5p | Pancreatic cancer | MNDR-E-MI-51807 |
MNDR | hsa-miR-455-5p | Malignant melanoma | MNDR-E-MI-51808 |
MNDR | hsa-miR-455-5p | Nephroblastoma | MNDR-E-MI-51809 |
MNDR | hsa-miR-455-5p | Colon cancer | MNDR-E-MI-51810 |
MNDR | hsa-miR-455-5p | Colon adenocarcinoma | MNDR-E-MI-51811 |
MNDR | hsa-miR-455-5p | Familial ovarian cancer | MNDR-E-MI-51812 |
MNDR | hsa-miR-455-5p | Basal cell carcinoma | MNDR-E-MI-51813 |
MNDR | hsa-miR-455-5p | Prostate adenocarcinoma | MNDR-E-MI-51814 |
MNDR | hsa-miR-455-5p | Glioma | MNDR-E-MI-51815 |
MNDR | hsa-miR-455-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-51816 |
MNDR | hsa-miR-455-5p | Osteosarcoma | MNDR-E-MI-51817 |
MNDR | hsa-miR-455-5p | Lung squamous cell carcinoma | MNDR-E-MI-51818 |
MNDR | hsa-miR-455-5p | Non-small cell lung adenocarcinoma | MNDR-E-MI-51819 |
MNDR | hsa-miR-455-5p | Lung adenocarcinoma | MNDR-E-MI-51820 |
MNDR | hsa-miR-455-5p | Thyroid carcinoma | MNDR-E-MI-51821 |
MNDR | hsa-miR-455-5p | Bladder urothelial carcinoma | MNDR-E-MI-51822 |
MNDR | hsa-miR-455-5p | Carcinoma renal cell | MNDR-E-MI-51823 |
MNDR | hsa-miR-455-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-51824 |
MNDR | hsa-miR-455-5p | Clear cell renal cell carcinoma | MNDR-E-MI-51825 |
MNDR | hsa-miR-455-5p | Large cell carcinoma | MNDR-E-MI-51826 |
MNDR | hsa-miR-455-5p | Cholangiocarcinoma | MNDR-E-MI-51827 |
MNDR | hsa-miR-455-5p | Lung small cell carcinoma | MNDR-E-MI-51828 |
MNDR | hsa-miR-455-5p | Synovial sarcoma | MNDR-E-MI-51829 |
MNDR | hsa-miR-455-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-51830 |
MNDR | hsa-miR-455-5p | Hepatocellular carcinoma | MNDR-E-MI-51831 |
MNDR | hsa-miR-455-5p | Familiar ovarian carcinoma | MNDR-E-MI-51832 |
MNDR | hsa-miR-455-5p | Barrett's adenocarcinoma | MNDR-E-MI-51833 |
MNDR | hsa-miR-455-5p | Hodgkin lymphoma | MNDR-E-MI-51834 |
MNDR | hsa-miR-455-5p | Tonsil cancer | MNDR-E-MI-51835 |
MNDR | hsa-miR-455-5p | Acute myelocytic leukemia | MNDR-E-MI-51836 |
MNDR | hsa-miR-455-5p | Colorectal cancer | MNDR-E-MI-51837 |
MNDR | hsa-miR-455-5p | Nasopharynx carcinoma | MNDR-E-MI-51838 |
MNDR | hsa-miR-455-5p | Nasopharyngeal cancer | MNDR-E-MI-51839 |
MNDR | hsa-miR-455-5p | Barrett's carcinogenesis | MNDR-E-MI-51840 |
MNDR | hsa-miR-455-5p | HPV | MNDR-E-MI-51841 |
MNDR | hsa-miR-455-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-51842 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | NCSTN | Homo sapiens | RR00986176 |
TOP